Enveric Biosciences, Inc. (ENVB)
2025-06-30 | ||||
|---|---|---|---|---|
| Foreign currency translation | 24,473 | |||
| Income tax expense | - | |||
| Research and development | 1,260,051 | |||
| General and administrative | 1,219,018 | |||
| Depreciation and amortization | 39,980 | |||
| Total operating expenses | 2,519,049 | |||
| Loss from operations | -2,519,049 | |||
| Other income | - | |||
| Interest (expense) income, net | -132 | |||
| Total other (expense) income | -132 | |||
| Net loss before income taxes | -2,519,181 | |||
| Net loss | -2,519,181 | |||
| Comprehensive loss | -2,494,708 | |||
| Net loss per share - basic | -0.97 | |||
| Net loss per share - diluted | -0.97 | |||
| Weighted average shares outstanding, basic | 2,595,728 | |||
| Weighted average shares outstanding, diluted | 2,595,728 | |||